CONVERSANO, ESTER
CONVERSANO, ESTER
DIPARTIMENTO DI MEDICINA MOLECOLARE
Mostra
prodotti
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.009 secondi).
A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance
2024 Conversano, E; Debiec, H; Colucci, M; Emma, F; Ronco, P; Vivarelli, M
A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood
2024 Riganati, M; Zotta, F; Candino, A; Conversano, E; Gargiulo, A; Scarsella, M; Lo Russo, A; Bettini, C; Emma, F; Vivarelli, M; Colucci, M
Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy
2024 Balestra, E; Barbi, E; Ceconi, V; Di Maso, V; Conversano, E; Pennesi, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A child with semaphorin 3b-associated membranous nephropathy effectively treated with obinutuzumab after rituximab resistance | 2024 | Conversano, E; Debiec, H; Colucci, M; Emma, F; Ronco, P; Vivarelli, M | |
| A novel flow cytometry panel to identify prognostic markers for steroid-sensitive forms of idiopathic nephrotic syndrome in childhood | 2024 | Riganati, M; Zotta, F; Candino, A; Conversano, E; Gargiulo, A; Scarsella, M; Lo Russo, A; Bettini, C; Emma, F; Vivarelli, M; Colucci, M | |
| Pioglitazone, a PPAR-y agonist, as one of the new therapeutic candidates for C3 glomerulopathy | 2024 | Balestra, E; Barbi, E; Ceconi, V; Di Maso, V; Conversano, E; Pennesi, M |